Trump Is Considering Another Thiel Associate to Lead FDA
- Biotech exec may face anti-abortion dissent over fetal test
- Srinivasan has called for ‘exit’ of tech community from U.S.
This article is for subscribers only.
President-elect Donald Trump is considering former biotechnology industry executive Balaji Srinivasan to lead the Food and Drug Administration, according to people familiar with the matter, putting another candidate in the running who is aligned with venture capitalist Peter Thiel.
Srinivasan co-founded Counsyl Inc. and helped develop a pregnancy test to quickly detect Down syndrome and other severe, chromosome-related birth defects. That could put him at odds with Republicans, since such tests are used early in pregnancy to help couples make decisions about abortion.